Muneeb Ul Haq | Contact X-ray Brachytherapy | Best Researcher Award

Dr. Muneeb Ul Haq  is a medical researcher and clinician currently pursuing an MD (Research) at the University of Liverpool , funded by the prestigious Horizon 2020 Marie Skłodowska-Curie scholarship . With an MBBS from Aga Khan University  and a strong academic background from Karachi Grammar School and Beaconhouse , he brings a unique blend of clinical experience and research expertise. His focus lies in developing clinical prediction models , especially in rectal cancer treatment using contact X-ray brachytherapy. Muneeb is also passionate about theatre  and public health advocacy, blending science and storytelling in impactful ways.

Publication Profiles

Orcid

Scopus

 Education & Experience 

 Education:

•  MD (Research), University of Liverpool (2023–Present) – Horizon 2020 Marie Curie Fellowship recipient

•  MBBS, Aga Khan University – Honours in Anatomy, Biochemistry, and Community Health

•  A-Levels, Karachi Grammar School – 4 A*s, 1 B

•  O-Levels, Beaconhouse – 7 A*s, 3 As

 Research Experience:

•  Lead Author – Scoping review & meta-analysis on CXB in rectal cancer (Journal of Cancer, under review)

•  Clinical model development from Clatterbridge Cancer Center CXB data (250+ patients)

•  Long-term CXB outcomes (350+ patients, 2003–2020)

•  2nd Author – Kidney transplant immunology study (PMID:36347493)

•  5th Author – HLA mismatch and graft survival (PMID:37302557)

Summary Suitability For The Award

Dr. Muneeb Ul Haq is a highly deserving candidate for the Best Researcher Award, recognized for his exemplary contributions to the fields of clinical oncology and transplant immunology, as well as his rigorous approach to evidence synthesis and prediction modeling. A recipient of the prestigious Marie Skłodowska-Curie Innovative Training Network scholarship (Horizon 2020 Grant No. 857894—CAST), Dr. Haq is currently pursuing his MD in Research at the University of Liverpool, where he continues to produce impactful, patient-centered research in oncology and evidence-based medicine.

 Professional Development

Dr. Muneeb Ul Haq consistently pursues professional growth through certifications and global workshops . He holds Basic Life Support certification (AHA) , HIPAA and OSHA compliance , and has completed CITI’s Biomedical Research Ethics program . He has enriched his research acumen through meta-analysis workshops  and global health programs including Harvard X’s “Improving Global Health” course . His involvement in IHI safety modules emphasizes patient-centered care . Muneeb demonstrates a proactive attitude in aligning clinical experience with research innovation, ensuring ethical, effective, and evidence-based healthcare practices .

 Research Focus 

Dr. Muneeb Ul Haq’s primary research focus revolves around oncology, particularly developing clinical prediction models for rectal cancer management using Contact X-ray Brachytherapy (CXB) . His work involves scoping reviews, meta-analyses , and patient-level data analytics from Clatterbridge Cancer Center, targeting improved patient stratification and personalized treatment plans . His research aims to bridge the gap between predictive analytics and oncologic outcomes in minimally invasive cancer therapies . With a multidisciplinary approach combining medicine, statistics, and public health, Dr. Haq contributes toward precision medicine and evidence-based care for rectal cancer patients worldwide .

 Awards & Honors 

•  Horizon 2020 Marie Skłodowska-Curie Fellowship (Grant No. 857894—CAST)

•  Best Play Award – ACT Annual Drama Fest 2018

•  Winner – LUMS Young Writers Workshop & Short Story Contest 2016

•  Director & Writer – Acclaimed plays “Deafening Silence” and “Koi Tou Rokhai” (Social impact themes)

•  Honours in Anatomy, Biochemistry & Community Health – AKU

Publication Top Noted

1. “Contact X-ray Brachytherapy in Rectal Cancer: A Systematic Review and Meta-Analysis” – European Journal of Surgical Oncology 🏥📘 | Year: 2025

2. “Contact X-ray Brachytherapy as a Sole Treatment in Selected Patients with Early Rectal Cancer – Multi-centre Study” – Clinical and Translational Radiation Oncology 🏥📄 | Year: 2024

3. “Sequence of Contact X-ray Brachytherapy (CXB) and External Beam Radiation (EBRT) in Organ-Preserving Treatment for Small Rectal Cancer” – Radiotherapy and Oncology 🏥📄 | Year: 2024

4. “2565: Clinical Prediction Models for Contact Brachytherapy in Managing Rectal Cancers: A Scoping Review” – Radiotherapy and Oncology 🏥📄 | Year: 2024

5. “HLA Mismatch is Important for 20-Year Graft Survival in Kidney Transplant Patients” – Transplant Immunology 🏥🧬 | Year: 2023